The Artima Developer Community
Sponsored Link

Java Buzz Forum
Oracle to buy drug-trial software company Phase Forward for $685 million

0 replies on 1 page.

Welcome Guest
  Sign In

Go back to the topic listing  Back to Topic List Click to reply to this topic  Reply to this Topic Click to search messages in this forum  Search Forum Click for a threaded view of the topic  Threaded View   
Previous Topic   Next Topic
Flat View: This topic has 0 replies on 1 page
Angsuman Chakraborty

Posts: 19816
Nickname: angsuman
Registered: Dec, 2003

Angsuman Chakraborty is the CEO and Chief Architect at Taragana
Oracle to buy drug-trial software company Phase Forward for $685 million Posted: Apr 16, 2010 1:10 PM
Reply to this message Reply

This post originated from an RSS feed registered with Java Buzz by Angsuman Chakraborty.
Original Post: Oracle to buy drug-trial software company Phase Forward for $685 million
Feed Title: Simple Thoughts - Java and Web Technology Blog
Feed URL: http://tech.gaeatimes.com/index.php/feed/
Feed Description: News and views as a Software Architect and Entrepreneur on Java and Web Software.
Latest Java Buzz Posts
Latest Java Buzz Posts by Angsuman Chakraborty
Latest Posts From Simple Thoughts - Java and Web Technology Blog

Advertisement
more images more images more images Oracle to buy Phase Forward for $685 million REDWOOD SHORES, Calif. — Oracle Corp. has agreed to buy Phase Forward Inc., which makes software used to manage clinical drug trials, for $685 million, the companies said Friday. Oracle, the leading maker of database software, plans to merge Waltham, Mass.-based Phase Forward into its Health .... Read the original article  : here.

Read: Oracle to buy drug-trial software company Phase Forward for $685 million

Topic: Twitter takes step toward making money by accepting ads _ in 140 characters or less, of course Previous Topic   Next Topic Topic: Intel 1Q profit nearly quadruples; company predicts increased profitability

Sponsored Links



Google
  Web Artima.com   

Copyright © 1996-2019 Artima, Inc. All Rights Reserved. - Privacy Policy - Terms of Use